Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cluster Randomized, Single-centre, Controlled, Parallel,12-month Prospective Study and Additional 12-month Follow-up in Africa of Malaria Incidence in a Community Setting Following Systematic Treatment of P. Falciparum Asymptomatic Carriers With Artemether-lumefantrine (Coartem® / Coartem® Dispersible)

NCT01256658 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT01256658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01256658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cluster Randomized, Single-centre, Controlled, Parallel,12-month Prospective Study and Additional 12-month Follow-up in Africa of Malaria Incidence in a Community Setting Following Systematic Treatment of P. Falciparum Asymptomatic Carriers With Artemether-lumefantrine (Coartem® / Coartem® Dispersible)
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2010
Completion date
July 31, 2012
Enrollment
14,075 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

malaria